Vertebroplasty and Kyphoplasty Market Report 2026

The vertebroplasty and kyphoplasty market size has grown strongly in recent years. It will grow from $1.04 billion in 2025 to $1.1 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of osteoporotic fractures, aging population growth, rising diagnosis of vertebral compression fractures, expansion of spinal intervention capabilities, improved access to imaging technologies.

The vertebroplasty and kyphoplasty market size is expected to see strong growth in the next few years. It will grow to $1.35 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing adoption of outpatient spine procedures, growing demand for rapid pain relief treatments, expansion of advanced spinal biomaterials, rising investments in minimally invasive devices, increasing focus on faster patient recovery. Major trends in the forecast period include increasing adoption of minimally invasive spine procedures, rising use of balloon kyphoplasty devices, growing demand for image-guided interventions, expansion of outpatient spine treatment settings, improved bone cement delivery technologies.

The increasing incidence of spinal injuries related to sports is expected to drive growth in the vertebroplasty and kyphoplasty markets in the coming years. Sports-related spinal injuries involve damage to the spine caused by participation in athletic or physical activities. The rise in these injuries includes conditions such as vertebral compression fractures, spondylolisthesis, and herniated discs, which often require minimally invasive treatments like vertebroplasty and kyphoplasty, involving the injection of bone cement into damaged vertebrae. For instance, in 2024, according to the National Spinal Cord Injury Statistical Center (NSCISC), a US-based nonprofit research registry, approximately 305,000 individuals (range 257,000-388,000) are living with traumatic spinal cord injury (tSCI) in the United States, with an annual incidence of about 18,000 new tSCI cases per year. Therefore, the increasing incidence of sports-related spinal injuries is driving growth in the vertebroplasty and kyphoplasty market.

Major companies operating in the vertebroplasty and kyphoplasty market are leveraging strategic partnerships to develop unipedicular balloon catheters for the treatment of vertebral compression fractures. Strategic partnerships involve companies combining their resources and expertise to achieve shared benefits and success. For instance, in June 2024, Medtronic Plc, an Ireland-based medical technology company, partnered with Merit Medical Systems Inc., a US-based medical device company. Through this collaboration, a unipedicular, steerable balloon catheter will be developed for treating vertebral compression fractures (VCF) in the United States. This partnership builds on the existing collaboration, with Merit already supplying Medtronic’s Kyphon Xpander Inflation Syringes for balloon kyphoplasty procedures. The Kyphon KyphoFlex system is designed to enable controlled, precise, and targeted cavity creation during vertebral augmentation. The introduction of the unipedicular solution complements Medtronic’s existing bipedicular balloon kyphoplasty offering, providing clinicians with greater flexibility and treatment options.

In September 2023, Globus Medical Inc., a US-based musculoskeletal solutions company, merged with NuVasive Inc. for an undisclosed amount. Through this merger, Globus Medical aims to strengthen its spine and orthopedic portfolio by incorporating NuVasive’s advanced minimally invasive spinal surgery systems, enabling technologies, and vertebral stabilization solutions that support procedures for vertebral compression fractures and spinal deformities. NuVasive Inc. is a US-based medical technology company specializing in innovative spinal surgery platforms for the treatment of complex spinal conditions.

Major companies operating in the vertebroplasty and kyphoplasty market are Cardinal Health, Johnson and Johnson (DePuy Synthes), Medtronic Plc., Stryker Corporation, GS Solutions Inc., Lepu Medical Technology (Beijing)Co.Ltd., Merit Medical Systems Inc., Globus Medical Inc., Alphatec Spine Inc., Rontis Corporation, Spectrum Plastics Group., SOMATEX Medical Technologies GmbH, Zavation LLC, MJ Surgical, Benvenue Medical, Joimax GmbH, Laurane Medical LLC, Spine Wave Inc., G21 S.r.l., BM Korea Co. LTD, Teknimed, Joline GmbH And Co. KG, SCW Medicath Ltd., Stöckli Medical AG, Jiangsu ChangMei Medtech Co.Ltd., IZI Medical Products.

North America was the largest region in the vertebroplasty and kyphoplasty market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty and kyphoplasty market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vertebroplasty and kyphoplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the vertebroplasty and kyphoplasty market by increasing costs of imported bone cement, cannulas, needles, imaging systems, and balloon devices used in spinal fracture treatments. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to dependence on imported specialized devices, while Asia-Pacific faces pricing pressure on advanced spinal equipment. These tariffs are raising procedural costs and affecting adoption rates. However, they are also encouraging domestic manufacturing of spinal devices, regional supply chain development, and innovation in cost-efficient vertebral repair technologies.

The vertebroplasty and kyphoplasty market research report is one of a series of new reports that provides vertebroplasty and kyphoplasty market statistics, including vertebroplasty and kyphoplasty industry global market size, regional shares, competitors with a vertebroplasty and kyphoplasty market share, detailed vertebroplasty and kyphoplasty market segments, market trends and opportunities, and any further data you may need to thrive in the vertebroplasty and kyphoplasty industry. This vertebroplasty and kyphoplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vertebroplasty and kyphoplasty are minimally invasive surgical procedures used to treat non-healing vertebral compression fractures (VCFs) in the spine. These techniques involve injecting polymethyl methacrylate (PMMA) into the vertebral body to provide structural support.

The main products used in vertebroplasty and kyphoplasty include kyphoplasty devices and vertebroplasty devices. Kyphoplasty devices are specialized medical instruments designed specifically for use in kyphoplasty procedures. They are utilized in vertebroplasty and kyphoplasty surgeries by hospitals and ambulatory surgical centers.

The vertebroplasty and kyphoplasty market consists of revenues earned by entities through services such as diagnostic evaluation services, consultations, post-operative care, and monitoring services to assist individuals with vertebral compression fractures and related conditions. The vertebroplasty and kyphoplasty market also includes sales of medical imaging equipment, pain management devices, and patient monitoring equipment that help in diagnosis, pain relief, and comprehensive patient care during and after procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.